rebetol medication guide

my male partner is taking solvadi and ribivarin and I just found out I am pregnant the doc told him to take precautions to avoid getting their partner pregnant but I cant find any information about how the medication effects when the male is taking the medicine and the female gets pregnant if anyone has any information on this please let me know I am so worried about whether everything is going to be okay with the baby or not

SVR for Peg-Intron plus Rebetol combination therapy is 41% for genotype 1, and 82% for genotypes 2 through 6. Peg-Intron is a reconstituted powder that is dosed according to a person's weight. Roche’s Pegasys plus Copegus: SVR for Pegasys plus Copegus combination therapy is 44-51% for genotype 1, and 70-82% for genotypes 2 through 6. Pegasys is a ready-made solution that is dosed at 180µg regardless of a person's weight.

That said you need to check out your Rebetol dose. Something is strange with your dosing. Generally, 800 mg Rebetol is the lowest dose given, while 150 mcg PegIntron is the highest. May I ask how much you weigh? Are you genotype 1? An easy way to look at if you are getting the correct weight based doses is to do these calculations: 1. Calculate your weight in kilos (your weight in lbs divided by 2.2). 2. Divide your ribavarin dose by your weight in kilos.

weakness,tired,confused,non tolerance of exercise,muscle weakness,sleep disturbance.center of headache, Taking only Metformin . You can please guide.

Additionally, the product labeling was update to include revisions to the text regarding the use of PegIntron in patients with neuropsychiatric disorders. Changes were made to the Medication Guide for consistency. The following changes were made to the product labeling. The Indication and Usage section was update as follows: PegIntron®, as part of a combination regimen, is indicated for the treatment of Chronic Hepatitis C in patients with compensated liver disease.

Among subjects with detectable HCV-RNA at TW8 who had attained undetectable HCV-RNA at TW24 and completed at least 28 weeks of treatment, the SVR rates were 66% (45/68) in VICTRELIS-RGT arm (4 weeks of PegIntron and REBETOL then 24 weeks of VICTRELIS with PegIntron and REBETOL followed by 20 weeks of PegIntron and REBETOL alone) and 75% (55/73) in VICTRELIS-PR48 arms (4 weeks of PegIntron and REBETOL then 44 weeks of VICTRELIS with PegIntron and REBETOL).

It is very difficult to know anything based on what you posted. First, lab ranges even for the different labs in the US differ so without ranges - have no idea if you are low, high or normal. Second - no idea if you are sick or how you are sick. The tests run are not really run for adrenal except DHEA (and that is really more of an adrogen - e.g. it converts to testosterone and estrogen) so not sure why it belongs in this forum.

Between copegus and rebetol which one is more effective for the treatment? Because copegus make me so weak. I prefer rebetol if they have the same effectiveness for the virus treatment.

• PegIntron + REBETOL for four weeks followed by VICTRELIS 800 mg three times daily + PegIntron + REBETOL for 24 weeks. The subjects were then continued on different regimens based on Treatment Week (TW) 8 through TW24 response-guided therapy (VICTRELIS-RGT). All subjects in this treatment arm were limited to 24 weeks of therapy with VICTRELIS.

In a 28-week treatment regimen in which patients received 4 weeks of PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) prior to the addition of boceprevir (800 mg TID), the rate of sustained virological response at 12 weeks after the end of treatment (SVR 12) was 57 percent (ITT).

(1) In a 48-week boceprevir regimen, the SVR rate was 74 percent at 12 weeks after the end of treatment (SVR 12) in patients who received 4 weeks of PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) prior to the addition of boceprevir (800 mg TID) (P/R lead-in). In a 28-week boceprevir regimen, the SVR rate was 56 percent at 24 weeks after the end of treatment (SVR 24) in patients who received the P/R lead-in.

Hi StephanCastlecrag, In actual ,, per doctor recommendation I should not be starting the medication for now. But I want to start the medication. I am HbeAg negative. But I want to start the Medication . On my insisting , Dr told me to start with Baraclude 0.5mg (Entecavir) . Should I start this or should go for Tenofovir ???? What is the major difference between the two ???

Pivotal Study in Previously Untreated (Naive) Patients The primary objective of this pivotal study, known as HCV SPRINT-2 (HCV Serine Protease Inhibitor Therapy-2), is to evaluate the efficacy of 28- and 48-week regimens of boceprevir (800 mg TID) in combination with PEGINTRON (1.5 mcg/kg/week) and REBETOL (600-1400 mg/day) compared to a control of PEGINTRON and REBETOL alone for 48 weeks in previously untreated (naive) adult patients with chronic HCV genotype 1.

06 that just completed a 60 week treatment of Peg-intron and Rebetol. I was undetected at 12 weeks and stayed undetected through out the treatment. Unfortunately, the virus was detected 6 weeks after I stopped the treatment. I would really appreciate your thoughts on what you think would be the best course of action at this point. Any insight would be greatly appreciated!

Is there a medication for hepatitis cheaper than inteferon and ribavirine that i can spend les than 100dollars a month? IF yes give me the name so that i can command it .

but sometime i have pain at that areas. Please guide me what should I do. Do i operate them or it can be treated by any medicine. This discussion is related to <a href='http://www.medhelp.org/posts/show/258235'>fibradenoma</a>.

Your doctor has created his own hybrid by using Merck's Victrelis but replacing Merck's rebetol/pegintron and their dosing recommendations with the correct dosing for pegasys/copegus if it was used with Incivek. Personally although this is off the beaten path I don't see a problem with it because many people experience less side effects with pegasys but the efficacy is similar.

VICTRELIS-treated subjects who demonstrated interferon responsiveness at TW4 achieved SVR rates of 81% (203/252) in VICTRELIS-RGT arm and 79% (200/254) in VICTRELIS-PR48 arm, compared to 52% (134/260) in subjects treated with PegIntron/REBETOL.

Had my first jab of Pegintron peginterferon alfa-2b yesterday and on 1200mg Rebetol daily. Not sure how long for this time. Bit of a hangover type feeling this morning but thats it for now.

not sure there is much of a difference but i have heard pegasys has less side effects.

Did the doctor test anything other than TSH? FREE T3 and FREE T4? Does your son have hypo symptoms?

Nobody here is qualified to tell you how to take your medication, only work with your doctor on this. He is the one who is qualified to know what is best for you. We can share our own experiences, but never change anything with your medicine unless your doctor suggests or allows it. Take care.....

My treatment nurse set me up on the program with Pegassist (Genentech Pegasys system): 1-888-941-3331 Peginterferon and Ribaviron Commitment to Care (Merck PEG-Intron system): 1-866-363-6379, opt 1 Hope that helps.

Among subjects with detectable HCV-RNA at TW8 who had attained undetectable HCV-RNA at TW24 and completed at least 28 weeks of treatment, the SVR rates were 66% (45/68) in VICTRELIS-RGT arm (4 weeks of PegIntron and REBETOL then 24 weeks of VICTRELIS with PegIntron and REBETOL followed by 20 weeks of PegIntron and REBETOL alone) and 75% (55/73) in VICTRELIS-PR48 arms (4 weeks of PegIntron and REBETOL then 44 weeks of VICTRELIS with PegIntron and REBETOL). http://www.fda.

because of insurance issues my medication can't be refilled at this time. will i be able to go back to treatment if my medication will not be avaiable untill next week? i am on INCEIVEK - PSY.

Rebetol medication guide

Common Questions and Answers about Rebetol medication guide

rebetol